Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
Acer Therapeutics Inc. (ACER)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Mar-05-23 | Dec-31-22 | Dec-05-22 | Sep-30-22 | Jun-30-22 |
| | 10-Q | 8-K | 10-Q | 8-K | 10-K | 8-K | 10-Q | 10-Q |
| Revenues | | 100.0% | | 100.0% | | 100.0% | | |
| Cost of goods sold | | 200.0% | | 200.0% | | 199.0% | | |
| Gross profit | | -100.0% | | -100.0% | | -99.0% | | |
| Selling, general and administrative | | | | | | 0.0% | | |
| Research and development | | | | | | | | |
| General and administrative | | 198.1% | | 106.1% | | 0.0% | | |
| Depreciation | | | | | | | | |
| EBIT | | -298.1% | | -206.1% | | -199.0% | | |
| Pre-tax income | | 0.0% | | 0.0% | | -354.8% | | |
| Income taxes | | 0.0% | | 0.0% | | 0.0% | | |
| Net income | | 0.0% | | 0.0% | | -354.8% | | |
|